Research halted on rimonabantSanofi-Aventis has discontinued further development of rimonabant for all therapeutic indications. Venlafaxine XR more dangerous than SSRIs in overdoseOverdose with venlafaxine may be associated with a higher risk of fatal outcome compared to overdose with selective serotonin reuptake inhibitor antidepressants, but lower than that seen with tricyclic antidepressants. First Previous 4 5 6
